|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07J 31/00 | |
| A61K 31/56 | |||
| A61P 5/44 |
| (11) | Patento numeris | 1472272 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03704759.4 |
| Europos patento paraiškos padavimo data | 2003-02-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-11-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-03-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2003/000478 |
| Data | 2003-02-04 |
| (87) | Numeris | WO 2003/066656 |
| Data | 2003-08-14 |
| (30) | Numeris | Data | Šalis |
| 67010 | 2002-02-04 | US |
| (72) |
BIGGADIKE, Keith GlaxoSmithKline, GB
COOTE, Steven John c/o GlaxoSmithKline, GB
CRAIG, Andrew GlaxoSmithKline, GB
CROWE, David Malcolm GlaxoSmithKline, GB
JACEWICZ, Victor Witold c/o GlaxoSmithKline, GB
MILLAN, Michael John GlaxoSmithKline, GB
NICE, Rosalyn Kay c/o GlaxoSmithKline, GB
NOGA, Brian c/o GlaxoSmithKline, US
SEAGER, John Frederick c/o GlaxoSmithKline, GB
THEOPHILUS, Andrew Lewis GlaxoSmithKline, GB
|
| (73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue,, Greenford, Middlesex UB6 0NN,
GB
|
| (54) | CRYSTALLINE COMPLEXES OF FLUTICASONE 2-FUROATE |
| CRYSTALLINE COMPLEXES OF FLUTICASONE 2-FUROATE |